The Congestive Heart Failure (CHF) Treatment Devices Market size is expected to grow from USD 20.50 billion in 2023 to USD 28.14 billion by 2028, at a CAGR.
A cardiac pacemaker is a tiny device that is surgically implanted in the chest to regulate a slow heartbeat. Three types of cardiac pacemakers exist: a
SUNNYVALE, Calif., Nov. 17, 2022 /PRNewswire/ EBR Systems, Inc. (ASX: "EBR", "EBR Systems", or the "Company"), developer of the world's only wireless cardiac pacing system for heart failure, is pleased to announce that the Company's WiSE technology will be featured at the 15th Asia Pacific Heart Rhythm Society (APHRS) Scientific Session in Singapore from the 18th to the 20th of November. The APHRS is a leading non-profit organisation that represents medical, allied health, and science professionals specialising in cardiac rhythm disorders in the Asia-Pacific region. The annual conference is a premier event featuring industry workshops and a core scientific programme delivered by international and regional speakers. Five abstracts featuring WiSE have been accepted for presentations, highlighting the technology's position at the forefront of innovation in the cardiac rhythm management landscape. Abstracts featuring WiSE at the APHRS scientific
SUNNYVALE, Calif., Nov. 17, 2022 /PRNewswire/ EBR Systems, Inc. (ASX: "EBR", "EBR Systems", or the "Company"), developer of the world's only wireless cardiac pacing system for heart failure, is pleased to announce that the Company's WiSE technology will be featured at the 15th Asia Pacific Heart Rhythm Society (APHRS) Scientific Session in Singapore from the 18th to the 20th of November. The APHRS is a leading non-profit organisation that represents medical, allied health, and science professionals specialising in cardiac rhythm disorders in the Asia-Pacific region. The annual conference is a premier event featuring industry workshops and a core scientific programme delivered by international and regional speakers. Five abstracts featuring WiSE have been accepted for presentations, highlighting the technology's position at the forefront of innovation in the cardiac rhythm management landscape. Abstracts featuring WiSE at the APHRS scientific